Increasing Physical Activity with a Social Robot-assisted Exercise Intervention in Older Adults with Hearing Loss: a Feasibility and Pilot Randomized Controlled Trial
- Conditions
- Age-related Hearing Loss
- Registration Number
- NCT06878339
- Lead Sponsor
- The Hong Kong Polytechnic University
- Brief Summary
Objectives To assess the feasibility and acceptability of using a home-based, social robot-assisted intervention (SRAI) for older adults with hearing loss (HL), and to examine the preliminary effects of SRAI on improving physical activity, loneliness, communication, and health-related quality of life in this population.
Hypothesis to be tested SRAI is feasible for implementation at home and acceptable to participants. Upon completing the 10-week intervention and the 1-month follow-up, the intervention group (IG) will report significantly greater improvements in measured outcomes. These findings will support subsequent investigations in a larger-scale randomized controlled trial (RCT).
Design and subjects A two-arm, single-blinded, pilot RCT with individual semi-structured interviews. Chinese adults aged 65 years or older, with mild-to-moderate HL with a pure-tone average of 20-50 dB across octave frequencies 0.5 to 4kHz in both ears.
Study instruments This study will feature a 2 kg, 30 cm tall and 20 cm wide, Cantonese-speaking humanoid social robot named KaKa.
Interventions Each IG participant will receive SRAI at home for 10 weeks. This will include auditory rehabilitation and 60 min/day, 3 days/week of varied multicomponent physical activity following the World Health Organization's evidence-based recommendations. The control group will engage in physical activity at the same intensity level and frequency as the IG without a robot.
Main outcome measures Physical activity levels.
Data analysis Descriptive statistics, an independent sample t-test or chi square test, generalized estimating equation and thematic analysis will be used.
Expected results Participants could benefit from incorporating tailored intervention for physical activity with auditory rehabilitation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 40
- ethnic Chinese aged ≥65 years old living at home;
- with mild to moderate HL with a pure-tone average of 20 to 50 dB across octave frequencies 0.5 to 4kHz in both ears;
- no cognitive impairment [score of ≦2 on the 5-item Abbreviated Memory Inventory for the Chinese (AMIC)]; and
- informed consent to participate in this study. Loneliness is not a pre-requisite for taking part in the research. Nevertheless, previous findings from a longitudinal cohort study indicate that approximately 46.6% of older adults with hearing loss reported feeling lonely.
- those with a diagnosis of a major neurocognitive disorder;
- a history of symptomatic stroke or other disease of the central nervous system;
- a serious medical or psychiatric illness (e.g., severe depression, schizophrenia, bi-polar disorder) or a visual impairment that would interfere with using a robot or using hearing aids and hearing assistive technologies;
- have limited access to electricity at home.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Physical activity levels (objectively) 10 weeks A wrist-worn ActiGraph GT3X+, valid step counter will be used to measure daily step-count.2
Physical activity levels (subjectively) 10 weeks will be measured using the Chinese version of the International Physical Activity Questionnaire.
- Secondary Outcome Measures
Name Time Method Loneliness 10 weeks will be measured using the 6-item De Jong Gierveld Loneliness Scale (Chinese version)
Communication 10 weeks will be measured using Chinese version of the Hearing Handicap Inventory for the elderly (HHIE)
Health-related quality of life (HRQL) 10 weeks will be assessed using the Medical Outcomes Study 36-item Short Form Health Survey (SF-36; Chinese version)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.